Condition
Degenerative Changes
Total Trials
4
Recruiting
0
Active
0
Completed
4
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 25/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
100%
4 of 4 completed with results
Key Signals
4 with results100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (4)
Trial Status
Completed4
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT02018445Not ApplicableCompletedPrimary
Accell Evo3™ Demineralized Bone Matrix in Instrumented Lumbar Spine Fusion
NCT01873586Not ApplicableCompletedPrimary
OsteoStrux™ Collagen Ceramic Scaffold in Instrumented Lumbar Spine Fusion
NCT01430299Not ApplicableCompleted
Efficacy and Safety of Accell Evo3 Demineralized Bone Matrix (DBM) in Instrumented Posterolateral Lumbar Spine Fusion
NCT01714804Not ApplicableCompleted
Efficacy and Safety of Integra Accell Evo3 DBM in Instrumented Lumbar Spine Fusion
Showing all 4 trials